Xarelto Lawsuit Plaintiff Alleges Blood-Thinning Drug Caused Life-Threatening Internal Bleed

February 26, 2016 – – BloodThinnerHelp.com reports on another lawsuit filed against Xarelto manufacturers Janssen Pharmaceuticals (a subdivision of Johnson & Johnson) and Bayer AG. The suit was initially filed in the Eastern District of New York, but has since been transferred with the formation of MDL No.2592 in Louisiana. It was filed by a Texas woman who claims that the defendants neglected to warn physicians and patients (including herself) about the possible dangerous side effects associated with their anticoagulant drug. In New York, her lawsuit was filed under case number 1:14-cv-04524.

Documents for this lawsuit show that the woman claims to have been prescribed Xarelto by her physician in order to prevent the occurrence of a stroke. She was at increased risk for this occurrence because of her atrial fibrillation condition. She also stated that she had only been using the blood thinner for 5 month’s time when she suffered from a sudden internal bleed which physicians termed life-threatening. Though she considers herself lucky to have survived this bleed, she claims that she will suffer with long-term medical needs because of it.

Xarelto received approval from the U.S. Food and Drug Administration in 2011 and successfully launched onto the market. It was a new-generation blood thinner, and one that suddenly required none of the physician monitoring, dietary restrictions, or dosage adjustments that other traditional blood thinners had. It became increasingly popular for these reasons. Xarelto was approved to treat patients recovering from hip and knee replacement surgeries, or those with pulmonary embolism and deep vein thrombosis. The approved uses were later expanded to include treatment for patients with atrial fibrillation, as a preventative measure for strokes.

Today, Xarelto lawsuits continue to be filed from across the nation, and number over 3,000. The Eastern Louisiana MDL contains over 2,800 cases consolidated by the U.S. Judicial Panel on Multidistrict Litigation, while another group of more than 550 lawsuits have been consolidated to form a mass tort in Philadelphia, Pennsylvania. All plaintiffs share common allegations that the blood thinner puts users at increased risk for sudden dangerous bleeding episodes.

As the plaintiffs wait for these cases to progress, case numbers steadily increase. Attorney Joseph Osborne is working to help ensure that anyone who feels that they have suffered health problems from using the blood thinner will have the opportunity to fully investigate their legal rights. Patients who used Xarelto and who suffered from health problems which they attribute to taking the drug may be entitled to significant compensation. To help those interested in pursuing justice, Attorney Osborne is currently offering free legal consultations for qualifying individuals.

To request further information on Xarelto lawsuits, or to ask questions, please contact Attorney Joseph Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008380